Use of Medications for Secondary Prevention After Coronary Bypass Surgery Compared With Percutaneous Coronary Intervention-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Use of Medications for Secondary Prevention After Coronary Bypass Surgery Compared With Percutaneous Coronary Intervention

Published:2013-01 Issue:3 Volume:61 Page:295-301
ISSN:0735-1097
Container-title:Journal of the American College of Cardiology
language:en
Short-container-title:Journal of the American College of Cardiology

Author:

Hlatky Mark A.,Solomon Matthew D.,Shilane David,Leong Thomas K.,Brindis Ralph,Go Alan S.

Funder

American Heart Association

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference29 articles.

1. AHA/ACCF secondary prevention and risk reduction therapy for patients with coronary and other atherosclerotic vascular disease: 2011 update;Smith;J Am Coll Cardiol,2011

2. 2011 ACCF/AHA guideline for coronary artery bypass graft surgery;Hillis;J Am Coll Cardiol,2011

3. 2011 ACCF/AHA/SCAI guideline for percutaneous coronary intervention;Levine;J Am Coll Cardiol,2011

4. Heart disease and stroke statistics—2012 update: a report from the American Heart Association;Roger;Circulation,2012

5. Patterns and predictors of statin use after coronary artery bypass graft surgery;Kulik;J Thorac Cardiovasc Surg,2007

Cited by 61 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Patterns of 12-Month Post-Myocardial Infarction Medication Use According to Revascularisation Strategy: Analysis of 15,339 Admissions in Victoria, Australia;Heart, Lung and Circulation;2024-07

2. Emulated Trial for Discharge Prescription of Guideline-Directed Medical Therapy and 15-Year Survival After Coronary Artery Bypass Graft Surgery;Mayo Clinic Proceedings;2024-05

3. Clinical Outcome in Post-ST Segment Elevation Myocardial Infarction Patients Receiving β-Blocker and Angiotensin-converting Enzyme Inhibitor/Angiotensin Receptor Blocker versus Receiving Either Therapy Alone: A Prospective Observational Study;Journal of Primary Care Specialties;2024-01

4. Defining the optimal approach to revascularization in chronic coronary syndrome patients with diabetes and multivessel disease: Is our equipoise evidence-based?;IJC Heart & Vasculature;2023-06

5. Impact of low-density lipoprotein cholesterol and lipoprotein(a) on mid-term clinical outcomes following coronary artery bypass grafting: A secondary analysis of the DACAB trial;Frontiers in Cardiovascular Medicine;2023-03-24

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3